DJIA 17,718.92 -38.99 -0.22%
NASDAQ 4,995.67 -17.45 -0.35%
S&P 500 2,072.24 -5.18 -0.25%
market minute promo

Celgene (NASDAQ: CELG)

119.77 1.55 (1.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $119.65 1.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $118.56
Previous Close $118.22
Daily Range $118.52 - $119.89
52-Week Range $82.90 - $129.06
Market Cap $95.0B
P/E Ratio 40.49
Dividend (Yield) $0.00 (0.0%)
Volume 2,249,617
Average Daily Volume 3,963,659
Current FY EPS $4.07

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

3 Common Pitfalls Biotech Investors Need to Learn to Avoid

Here is a look at three common mistakes investors make when buying biotech stocks.

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Pre

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Press Releases

IBB, CELG, AMGN, REGN: Large Inflows Detected at ETF

Celgene Is Fairly Valued But Looks To Be Making Lower Highs

What Is Beyond Vision-Loss Blockbuster For Regeneron?

Celgene: The Juno Therapeutics Deal Is Worth The Premium

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Ana

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog

Stock Market News for July 01, 2015 - Market News

Market Inefficiency Offers Discount On Agios

Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnion

See More CELG News...

CELG's Top Competitors

CELG $119.77 (1.31%)
Current stock: CELG
AMGN $153.55 (-0.93%)
Current stock: AMGN
GILD $115.22 (-0.68%)
Current stock: GILD
$0.00 (0.00%)
Current stock: